Michigan Taps Orchid Cellmark for Paternity Testing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark will provide its DNA paternity testing services to the State of Michigan under a new contract valued at around $5.2 million, the company said today.

The firm said that the contract enables it to provide its services to the Michigan Department of Human Services' Office of Child Support and the Children's Protective Services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.